Patents by Inventor A. O. Magnus Hook

A. O. Magnus Hook has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090048163
    Abstract: Mouse asporin protein and nucleic acid sequences are disclosed. The protein contains a unique aspartic acid region near the N-terminus. The central domain contains ten leucine rich repeats. Sequences consistent with other class I small leucine rich repeat proteoglycans (SLRP) are also observed. Methods of use for the protein include regulating the complement system, inhibiting fibrosis formation, regulating the growth of endothelial cells and angiogenesis, regulating or inhibiting the growth of cancer cells, and regulating the functions of neuromuscular junctions.
    Type: Application
    Filed: October 30, 2007
    Publication date: February 19, 2009
    Inventors: Stephen P. Henry, A.O. Magnus Hook, Richard Mayne
  • Patent number: 7304137
    Abstract: Mouse asporin protein and nucleic acid sequences are disclosed. The protein contains a unique aspartic acid region near the N-terminus. The central domain contains ten leucine rich repeats. Sequences consistent with other class I small leucine rich repeat proteoglycans (SLRP) are also observed. Methods of use for the protein include regulating the complement system, inhibiting fibrosis formation, regulating the growth of endothelial cells and angiogenesis, regulating or inhibiting the growth of cancer cells, and regulating the functions of neuromuscular junctions.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: December 4, 2007
    Assignee: The Texas A & M University System
    Inventors: Stephen P. Henry, A. O. Magnus Hook, Richard Mayne
  • Publication number: 20030148351
    Abstract: Mouse asporin protein and nucleic acid sequences are disclosed. The protein contains a unique aspartic acid region near the N-terminus. The central domain contains ten leucine rich repeats. Sequences consistent with other class I small leucine rich repeat proteoglycans (SLRP) are also observed. Methods of use for the protein include regulating the complement system, inhibiting fibrosis formation, regulating the growth of endothelial cells and angiogenesis, regulating or inhibiting the growth of cancer cells, and regulating the functions of neuromuscular junctions.
    Type: Application
    Filed: December 13, 2002
    Publication date: August 7, 2003
    Inventors: Stephen P. Henry, A.O. Magnus Hook, Richard Mayne